AARTIPHARM — Aarti Pharmalabs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹45.20bn
- IN₹46.18bn
- IN₹19.45bn
- 47
- 25
- 71
- 44
Annual cashflow statement for Aarti Pharmalabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | Interim Report | Interim Report | ARS |
| Standards: | — | — | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.046 | 1,554 | 2,608 |
| Depreciation | |||
| Non-Cash Items | — | 103 | 202 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.046 | -2,515 | -805 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Accounts Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 0 | -437 | 2,630 |
| Capital Expenditures | — | -1,412 | -1,197 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | 24.1 | -381 |
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | — | -1,387 | -1,578 |
| Financing Cash Flow Items | — | -120 | -211 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | — | 2,604 | -1,635 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 779 | -583 |